ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Osteoarthritis"

  • Abstract Number: 2141 • 2014 ACR/ARHP Annual Meeting

    Sensitivity to Change of Joint Space Width Measurements in Hand Osteoarthritis in a Two Year Follow-up Study

    W. Damman1, S.E. de Bruin1, B.C. Stoel2, R. van 't Klooster2 and M. Kloppenburg1, 1Rheumatology, Leiden University Medical Center, Leiden, Netherlands, 2Radiology, Leiden University Medical Center, Leiden, Netherlands

    Background/Purpose: Cartilage loss, represented by joint space width (JSW) on radiographs, is an important outcome measure in hand OA disease course. JSW can be assessed…
  • Abstract Number: 219 • 2014 ACR/ARHP Annual Meeting

    DXA Body Composition, Sarcopenia and Knee and Hip Osteoarthritis: Results from the Khoala Cohort

    Clémence Jeanmaire1, Isabelle Chary-Valkenaere1, Damien Loeuille2, Lorraine Bernard3 and Anne-Christine Rat,4, 1Rheumatology, CHU Nancy, Vandoeuvre Les Nancy, France, 2Rheumatology, CHU Brabois, Vandoeuvre les Nancy, France, 3CHU Nancy, Pôle S2R, Epidémiologie et Evaluation Cliniques, INSERM, CIC-EC, CIE6, Vandoeuvre Les Nancy, France, 4Université de Lorraine, Nancy, F-54000, France; Inserm, , CIC-EC, CIC 1433, Nancy, F-54000, France; CHU de Nancy, Clinical Epidemiology and Evaluation Department, Nancy, F-54000, France; CHU de Nancy, Rheumatology department, Nancy, France

    Background/Purpose Obesity is a well known risk factor for the development and progression of knee osteoarthritis (OA), and to a lesser extent of hip OA.…
  • Abstract Number: 1969 • 2014 ACR/ARHP Annual Meeting

    Neurotrophin Receptor p75 (CD271) Defines a Distinct Synovial Fibroblast Subset in Rheumatoid and Osteoarthritic Synovial Tissues with Enhanced Proinflammatory Potential

    Manuel J. Del Rey1, Regina Faré1, Gabriel Criado2, Alicia Usategui1, Vanessa Miranda1, Juan D. Cañete3 and Jose L. Pablos1, 1Servicio de Reumatología, Instituto de Investigación Hospital 12 de Octubre (I+12), Madrid, Spain, 2Grupo de Enfermedades Inflamatorias y Autoinmunes, Instituto de Investigación Hospital 12 de Octubre (I+12), Madrid, Spain, 3Arthritis Unit. Rheumatology Department, Hospital Clínic of Barcelona, Barcelona, Spain

    Background/Purpose Synovial mesenchynmal or stromal cells constitute a heterogeneous cell population difficult to characterize ex vivo due to a paucity of cell markers and are…
  • Abstract Number: 207 • 2014 ACR/ARHP Annual Meeting

    Changes in Knee Compartment Distriubtion of Cartilage Loss and Bone Marrow Lesions over 7 Years: The MOST Study

    Joshua Stefanik1, Ali Guermazi2, Jingbo Niu3, Frank Roemer4, C.E. Lewis5, Neil A. Segal6, Michael Nevitt7 and David T. Felson8, 1Clinical Epidemiology, Boston University, Boston, MA, 2Radiology, Boston University School of Medicine, Boston, MA, 3Clinical Epidemiology Research and Training Unit, Boston University, Boston, MA, 4Klinikum Augsburg, Augsburg, Germany, 5University of Alabama at Birmingham, Birmingham City, AL, 6Orthopaedics and Rehabilitation, University of Iowa, Iowa City, IA, 7Epidemiology and Biostatistics, UCSF, San Francisco, CA, 8Clinical Epidemiology Research & Training Unit, Boston University School of Medicine, Boston, MA

    Background/Purpose: Knee osteoarthritis (OA) occurs in both the patellofemoral joint (PFJ) and tibiofemoral joint (TFJ). Little is known about the natural history of OA and…
  • Abstract Number: 1820 • 2014 ACR/ARHP Annual Meeting

    Discordance of Hip Pain with Radiographic Hip Osteoarthritis: The Osteoarthritis Initiative

    Chan Kim1, Michael C. Nevitt2, Pia M. Jungmann3, Irina Tolstykh4, Nancy E. Lane5, Thomas M. Link6 and David T. Felson7, 1Rheumatology, Boston University, Boston, MA, 2Epidemiology & Biostatistics, UCSF (University of California, San Francisco), San Francisco, CA, 3Radiology, Technische Universitaet Muenchen, Munich, Germany, 4Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, CA, 5Internal Medicine, Center for Musculoskeletal Health, UC Davis School of Medicine, Sacramento, CA, 6Musculoskeletal Quantitative Imaging Research Group, Department of Radiology and Biomedical Imaging, University of California, San Francisco, San Francisco, CA, 7Arthritis Research UK Centre for Epidemiology, Institute of Inflammation and Repair, University of Manchester, Manchester, United Kingdom

    Background/Purpose It is assumed that persons with hip pain from osteoarthritis (OA) are likely to have radiographic OA, making it possible to readily diagnose disease,…
  • Abstract Number: 200 • 2014 ACR/ARHP Annual Meeting

    Leg Length Inequality and Hip Osteoarthritis

    Chan Kim1, Jingbo Niu2, Mary Clancy3, Ali Guermazi4, Michael C. Nevitt5, Neil A. Segal6, William F. Harvey7, Cora E Lewis8 and David T. Felson9, 1Rheumatology, Boston University, Boston, MA, 2Clinical Epidemiology Research and Training Unit, Boston University, Boston, MA, 3Clinical Epidemiology, Boston University Sch Med, Boston, MA, 4Radiology, Boston University School of Medicine, Boston, MA, 5Epidemiology & Biostatistics, UCSF (University of California, San Francisco), San Francisco, CA, 6Orthopaedics and Rehabilitation, University of Iowa, Iowa City, IA, 7Rheumatology, Tufts Medical Center, Boston, MA, 8Division of Preventive Medicine, University of Alabama Birmingham School of Medicine, Birmingham, AL, 9Arthritis Research UK Centre for Epidemiology, Institute of Inflammation and Repair, University of Manchester, Manchester, United Kingdom

    Background/Purpose Leg length inequality (LLI), a side-to-side difference in lower limb lengths, is common.  In the Multicenter Osteoarthritis Study (MOST), in persons with LLI, the…
  • Abstract Number: 1800 • 2014 ACR/ARHP Annual Meeting

    Objectively Measured Sedentary Behavior Is a Distinct Risk Factor from Low Moderate-to-Vigorous Activity in Predicting Subsequent Frailty: Evidence from Osteoarthritis Initiative

    Jing Song1, Lee A. Lindquist1, Rowland W. Chang1, Pamela A. Semanik2, Linda S. Ehrlich-Jones3, Jungwha Lee4, Min-Woong Sohn1 and Dorothy D. Dunlop1, 1Northwestern University Feinberg School of Medicine, Chicago, IL, 2Rush University Medical Center, Chicago, IL, 3Rehabilitation Institute of Chicago, Chicago, IL, 4Preventive Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL

    Background/Purpose: Physical frailty represents a state of high vulnerability for adverse health outcomes including disability and mortality. Physical activity interventions to improve health have largely…
  • Abstract Number: 197 • 2014 ACR/ARHP Annual Meeting

    Differences in Total Hip Replacement Outcomes Based on Age

    Leslie Harrold1, David Ayers2, Wenjun Li2, Courtland Lewis3, Philip Noble4, Regis O'Keefe5, Jeroan Allison6 and Patricia D. Franklin2, 1Department of Orthopedics and Medicine, University of Massachusetts Medical School, Worcester, MA, 2Orthopedics and Physical Rehabilitation, University of Massachusetts Medical School, Worcester, MA, 3Hartford Hospital, Hartford, CT, 4Baylor College of Medicine, Houston, TX, 5University of Rochester Medical Center, Rochester, NY, 6Quantitative Health Sciences, University of Massachusetts Medical School, Worcester, MA

    Background/Purpose:  The fastest growing segment of patients who undergo total hip replacement (THR) are younger than 130 surgeons across 22 states in the US.  The…
  • Abstract Number: 1420 • 2014 ACR/ARHP Annual Meeting

    Non-Use of Glucocorticoid and Osteoarthritis Absence As Predictors of Clinical Remission in AR

    Salvador Loredo-Alanís1, David Vega-Morales2, Mario Garza-Elizondo1, Mario Garcia-Pompermayer3, Roberto Negrete-López1, Daniel Treviño-Montes1 and Diana Flores-Alvarado2, 1Departamento de Medicina Interna del Hospital Universitario “Dr. José Eleuterio González”, Universidad Autónoma de Nuevo León, Servicio de Reumatología, Departamento de Medicina Interna del Hospital Universitario “Dr. José Eleuterio González”, Universidad Autónoma de Nuevo León, Monterrey, Mexico, 2Rheumatology, Hospital Universitario UANL, Monterrey, Mexico, 3Departamento de Medicina Interna del Hospital Universitario “Dr. José Eleuterio González”, Universidad Autónoma de Nuevo León, Servicio de Reumatología, Departamento de Medicina Interna del Hospital Universitario “Dr. José Eleuterio González”, Universidad Autónoma de Nuevo León, Monterey, Mexico

    Background/Purpose The clinical evaluation of Rheumatoid arthritis (RA) is accomplished with compound indexes allowing better clinical decision. Clinical remission nowadays is an attainable target in…
  • Abstract Number: 187 • 2014 ACR/ARHP Annual Meeting

    Revision Arthroplasty in Rheumatoid and Osteoarthritis: Does Methotrexate Decrease Radiographic Lucency in RA Patients?

    Mike Wei1, Douglas N. Mintz2, Lisa A. Mandl3, Arielle Fein4, Jayme C. Burket5, Yuo-Yu Lee4, Wei-Ti Huang6, Vivian P. Bykerk4, Mark P. Figgie7, Edward F. DiCarlo8, Bruce N. Cronstein9 and Susan M. Goodman3, 1Weill Cornell Medical College, New York, NY, 2Radiology, Hospital for Special Surgery, New York, NY, 3Rheumatology, Hospital for Special Surgery, New York, NY, 4Hospital for Special Surgery, New York, NY, 5Healthcare Research Institute, Hospital for Special Surgery, New York, NY, 6Biostatistics, Hospital for Special Surgery, New York, NY, 7Orthopedics, Hospital for Special Surgery, New York, NY, 8Pathology, Hospital for Special Surgery, New York, NY, 9NYU School of Medicine, Division of Rheumatology, New York, NY

    Background/Purpose Rheumatoid arthritis (RA) patients have excellent total hip arthroplasty (THA) survival, and methotrexate (MTX), an anti-inflammatory disease modifying drug which may affect bone reabsorption,…
  • Abstract Number: 2254 • 2013 ACR/ARHP Annual Meeting

    Complementary and Alternative Medicine in Rheumatoid Arthritis – Persistently High Use Over the Past Decade Despite Advent of Biologics

    Dana DiRenzo1,2, Haiyan Sun3, H. Lester Kirchner3 and Eric D. Newman4, 1Rheumatology, Geisinger Medical Center, Danville, PA, 2Internal Medicine, University of Maryland Medical Center, Baltimore, MD, 3Geisinger Center for Health Research, Geisinger Health System, Danville, PA, 4Department of Rheumatology, Geisinger Health System, Danville, PA

    Background/Purpose: Complementary and Alternative Medicine (CAM) is commonly used when traditional medicine cannot reliably alter the disease.  Over the past decade, rheumatoid arthritis (RA) treatment…
  • Abstract Number: 1378 • 2013 ACR/ARHP Annual Meeting

    Associations Of Periodontitis (PD) With Established Seropositive Rheumatoid Arthritis are Independent of Smoking and Other Risk Factors

    Ted R. Mikuls1, Jeffrey Payne2, Fang Yu3, Geoffrey M. Thiele4, Richard J. Reynolds5, Grant W. Cannon6, Jeffrey Markt7, David McGowan8, Gail S. Kerr9, Robert Redman10, Andreas M. Reimold11, Garth Griffiths12, Mark Beatty2, Shawneen Gonzalez2, Debra Bergman13, Bartlett C. Hamilton III14, Alan R. Erickson1 and James R. O'Dell15, 1Omaha VA Medical Center and University of Nebraska Medical Center, Omaha, NE, 2College of Dentistry, University of Nebraska Medical Center, Lincoln, NE, 3University of Nebraska Medical Center, Omaha, NE, 4Int Med/Sec of Rheum/Immun, Univ of Nebraska Med Ctr, Omaha, NE, 5Clinical Immunology and Rheumatology, University of Alabama at Birmingham, Birmingham, AL, 6Division of Rheumatology, Salt Lake City VA and University of Utah, Salt Lake City, UT, 7Otol-Head and Neck Surgery, University of Nebraska Medical Center, Omaha, NE, 8Dentistry, George E. Wahlen VA Medical Center, Salt Lake City, UT, 9Rheumatology, Washington DC VAMC, Georgetown and Howard University, Washington, DC, 10Dentistry, Washington DC VA, Georgetown and Howard University, Washington, DC, 11Rheumatology, Dallas VA and University of Texas Southwestern, Dallas, TX, 12Dentistry, Dallas VA and University of Texas Southwestern, Dallas, TX, 13Internal Medicine, University of Nebraska Medical Center, Omaha, NE, 14University of Nebraska Medical Center and Omaha VA Medical Center, Omaha, NE, 15Dept of Internal Medicine, University of Nebraska Medical Center, Omaha, NE

    Background/Purpose: Periodontitis (PD) has been proposed as a risk factor in RA.  Reports have suggested that this association may be due to confounding from smoking…
  • Abstract Number: 97 • 2013 ACR/ARHP Annual Meeting

    Incidence and Trend Of Osteoarthritis In An Administrative Database From British Columbia, Canada

    M Mushfiqur Rahman1,2, Jolanda Cibere3,4, Charles H Goldsmith2,5, Aslam H. Anis6,7 and Jacek A. Kopec1,8, 1School of Population and Public Health, University of British Columbia, VANCOUVER, BC, Canada, 2Biostatistics, Arthritis Research Centre of Canada, Richmond, BC, Canada, 3Department of Medicine, University of British Columbia, VANCOUVER, BC, Canada, 4Division of Rheumatology, Arthritis Research Centre of Canada, Richmond, BC, Canada, 5Health Sciences, Simon Fraser University, Burnaby, BC, Canada, 6St. Paul's Hospital, Centre for Health Evaluation and Outcome Sciences, Vancouver, BC, Canada, 7School of Population and Public Health, University of British Columbia, Vancouver, BC, Canada, 8Arthritis Research Centre of Canada, Richmond, BC, Canada

    Background/Purpose: Data on the incidence of osteoarthritis (OA) are limited and there is little information on the trend in incidence of OA over time. The…
  • Abstract Number: 2149 • 2013 ACR/ARHP Annual Meeting

    Safety Of Lower-Dose Diclofenac Submicron Particle Capsules Dosed Up To 12 Weeks In Patients With Osteoarthritis

    Clarence Young1 and Marc C. Hochberg2, 1Iroko Pharmaceuticals, Philadelphia, PA, 2Medicine, University of Maryland School of Medicine, Baltimore, MD

    Background/Purpose: Osteoarthritis (OA) is the most common cause of disability in the US and is frequently managed with non-steroidal anti-inflammatory drugs (NSAIDs). NSAIDs, including diclofenac,…
  • Abstract Number: 1250 • 2013 ACR/ARHP Annual Meeting

    Serological Markers Of Structural Integrity and Inflammation Is Associated With Pain In Osteoarthritis

    Anne Sofie Siebuhr1, Lars Arendt-Nielsen2, Thomas Navndrup Eskehave3, Morten Asser Karsdal4, Kristian Kjaer Petersen5, Ole Simonsen6 and Anne C. Bay-Jensen7, 1Cartilage Biomarkers and Research, Nordic Bioscience, Herlev, Denmark, 2Department of Health Science and Technology, Faculty of Medicine, Aalborg University, Center for Sensory-Motor Interaction, Aalborg, Denmark, 3Center for Clinical and Basic Research and C4Pain, Aalborg, Denmark, 4Nordic Bioscience, Biomarkers and Research, Herlev, Denmark, 5Department of Health Science and Technology, Faculty of Medicine, Aalborg University, Denmark, Center for Sensory-Motor Interaction, Aalborg, Denmark, 6Frederikshavn Hospital, Frederikshavn, Denmark, 7Rheumatology, Nordic Bioscience, Biomarkers and Research, Herlev, Denmark

    Background/Purpose: Pain is associated with diagnosed osteoarthritis (OA), but little clinically association is found between joint integrity and the pain the individual patient experience. Peripheral…
  • « Previous Page
  • 1
  • …
  • 55
  • 56
  • 57
  • 58
  • 59
  • …
  • 63
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

ACR Abstract Embargo Policy

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. Academic institutions, private organizations and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part a scientific presentation or presentation of additional new information that will be available at the time of the meeting) is under embargo until Saturday, November 11, 2023.

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying financial and other sponsors about this policy. If you have questions about the abstract embargo policy, please contact the public relations department at [email protected].

Copyright Policy

View ACR Policies.

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology